BlackBerry and NantHealth unveiled the first secure clinical genome browser that gives doctors access to patients’ genetic data on the BlackBerry Passport smartphone.

The first in a series of offerings being developed jointly by the two companies, the NantOmics Cancer Genome Browser enables interactive reporting on genomics data for physicians and other providers in clinical settings.

“The proprietary NantOmics Cancer Genome Browser enables clinicians for the first time to investigate a tumor genome from the full three billion bases down to the single-base level in real-time, thanks to the power of the NantOmics supercomputing infrastructure,” said Patrick Soon-Shiong, M.D., founder and CEO of NantHealth. “This integrates with NantHealth’s treatment recommendation engine, Eviti, to personalize treatment protocols to individual patients based on their genomic signature.”

The Browser is fully encrypted to allow deployment in a HIPAA-secured environment.The Browser is fully encrypted to allow deployment in a HIPAA-secured environment, providing clinicians with access to patient data while on the go.

“Now with BlackBerry’s partnership and through the power of the cloud and secure networks, the reality is we are now able to put dozens of supercomputers, through mobile devices, into doctor’s hands on a global basis,” Soon-Shiong added. “Our goal is to extend this unique capability from doctor to patient, thereby establishing patient empowered 21st century health.”

BlackBerry is one of NantHealth’s investors. The NantOmics Cancer Genome Browser will be demonstrated at the upcoming CES in Las Vegas, and will be preloaded on BlackBerry Passport devices and available to the professional community in early 2015.